Evidence map›Paper›PMID 31461307›Full record

ReviewAmerican journal of physiology. Regulatory, integrative and comparative physiology2019

Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Ashley J Smuder

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of physiology. Regulatory, integrative and comparative physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cancer Cachexia.Advances in experimental medicine and biology · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Ashley J SmuderDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida.
University of Florida · US

Funding

Doxorubicin cardiotoxicity and the protective effects of exerciseR01HL144858 · NHLBI · UNIVERSITY OF FLORIDA · PI SMUDER, ASHLEY · 2019 to 2023
$1.9M
Doxorubicin-induced respiratory dysfunction and the protective effects of exerciseR01HL146443 · NHLBI · UNIVERSITY OF FLORIDA · PI SMUDER, ASHLEY · 2019 to 2023
$1.9M
NHLBI NIH HHS R01 HL144858NHLBI NIH HHS R01 HL146443
6 · The paper itself

Abstract

Doxorubicin (DOX) is a highly effective antitumor agent used for the treatment of a wide range of cancers. Unfortunately, DOX treatment results in cytotoxic side effects due to its accumulation within off-target tissues. DOX-induced cellular toxicity occurs as a result of increased oxidative damage, resulting in apoptosis and cell death. While there is no standard-of-care practice to prevent DOX-induced toxicity to healthy organs, exercise has been shown to prevent cellular dysfunction when combined with DOX chemotherapy. Endurance exercise stimulates numerous biochemical adaptations that promote a healthy phenotype in several vulnerable tissues without affecting the antineoplastic properties of DOX. Therefore, for the development of an effective strategy to combat the pathological effects of DOX, it is important to determine the appropriate exercise regimen to prescribe to cancer patients receiving DOX therapy and to understand the mechanisms responsible for exercise-induced protection against DOX toxicity to noncancer cells. This review summarizes the cytotoxic effects of DOX on the heart, skeletal muscle, liver, and kidneys and discusses the current understanding of the clinical benefits of regular physical activity and the potential mechanisms mediating the positive effects of exercise on each organ system.

Indexed as

Exercise TherapyAdaptation, PhysiologicalAnimalsAntibiotics, AntineoplasticAwards and PrizesCardiotoxicityChemical and Drug Induced Liver InjuryCytoprotectionDoxorubicinHeart DiseasesHumansKidney DiseasesMuscular DiseasesMyotoxicityPhysical EnduranceProtective FactorsAntibiotics, AntineoplasticDoxorubicinAdriamycinanthracyclineantioxidantschemotherapymitochondria

Identifiers

PMID31461307
PMCPMC6879842
OpenAlexW2971242056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.